title: Arginine improves microcirculation in the free transverse rectus abdominis myocutaneous flap after breast reconstruction: a randomized, double-blind clinical trial.
abstract: BACKGROUND
  Partial flap loss is caused by the incapability of the vascular pedicle to provide sufficient microvascular perfusion in distal segments of the flap in addition to the reperfusion injury that occurs in the whole flap after free tissue transfer. In experimental studies, the amino acid arginine reduces reperfusion injury and improves microvascular perfusion. The purpose of this clinical study was to explore the effect of arginine in free flap surgery.
  
  
  METHODS
  In this randomized, double blind, placebo-controlled trial, 20 patients with unilateral breast reconstruction using the free transverse rectus abdominis myocutaneous flap were included. Patient and flap data were recorded. Patients received a continuous intravenous infusion of arginine or the control amino acid alanine for 5 days. Microcirculation was recorded in the flap in a standardized fashion using laser Doppler flowmetry (Perimed).
  
  
  RESULTS
  Zone IV microcirculatory blood flow postoperatively was higher in the arginine group than in the alanine control group (p = 0.04).
  
  
  CONCLUSIONS
  The authors' study shows beneficial effects of intravenous therapy with arginine to improve microcirculation in the free transverse rectus abdominis myocutaneous flap.
authors: Maastricht, The Netherlands From the Department of Plastic, Reconstructive, and Hand Surgery, Maastricht University Medical Center.
authors: Darren I
authors: DI
authors: Booi
authors: Iris B J G
authors: IBJG
authors: Debats
authors: Nicolaas E P
authors: NEP
authors: Deutz
authors: Rene R W J
authors: RRWJ
authors: van der Hulst
references: Khouri RK, Cooley BC, Kunselman AR, et al. A prospective study of microvascular free-flap surgery and outcome. Plast Reconstr Surg. 1998;102:711–721.
references: Taylor GI, Palmer JH. The vascular territories (angiosomes) of the body: Experimental study and clinical applications. Br J Plast Surg. 1987;40:113–141.
references: Kroll SS. Fat necrosis in free transverse rectus abdominis myocutaneous and deep inferior epigastric perforator flaps. Plast Reconstr Surg. 2000;106:576–583.
references: Towpik E, Mazur S, Witwicki T, Tchorzewska H, Jackiewicz P. Elevating the island: The simplest method of delaying the TRAM flap. Ann Plast Surg. 2000;45:240–243.
references: Siemionow M, Arslan E. Ischemia/reperfusion injury: A review in relation to free tissue transfers. Microsurgery 2004;24:468–475.
references: Harder Y, Amon M, Laschke MW, et al. An old dream revitalised: Preconditioning strategies to protect surgical flaps from critical ischaemia and ischaemia-reperfusion injury. J Plast Reconstr Aesthet Surg. 2008;61:503–511.
references: Uhlmann D, Scommotau S, Witzigmann H, Spiegel HU. Exogenous L-arginine protects liver microcirculation from ischemia reperfusion injury. Eur Surg Res. 1998;30:175–184.
references: Huk I, Nanobashvili J, Neumayer C, et al. L-arginine treatment alters the kinetics of nitric oxide and superoxide release and reduces ischemia/reperfusion injury in skeletal muscle. Circulation 1997;96:667–675.
references: Kurose I, Wolf R, Grisham MB, Granger DN. Modulation of ischemia/reperfusion-induced microvascular dysfunction by nitric oxide. Circ Res. 1994;74:376–382.
references: Chattopadhyay P, Verma N, Verma A, Kamboj T, Khan NA, Wahi AK. L-arginine protects from pringle manoeuvere of ischemia-reperfusion induced liver injury. Biol Pharm Bull. 2008;31:890–892.
references: Kandilci HB, Gumusel B, Topaloglu E, et al. Effects of ischemic preconditioning on rat lung: Role of nitric oxide. Exp Lung Res. 2006;32:287–303.
references: Soos P, Andrási T, Buhmann V, et al. Myocardial protection after systemic application of L-arginine during reperfusion. J Cardiovasc Pharmacol. 2004;43:782–788.
references: Albrecht EW, Stegeman CA, Heeringa P, Henning RH, van Goor H. Protective role of endothelial nitric oxide synthase. J Pathol. 2003;199:8–17.
references: Ozaki M, Kawashima S, Hirase T, et al. Overexpression of endothelial nitric oxide synthase in endothelial cells is protective against ischemia-reperfusion injury in mouse skeletal muscle. Am J Pathol. 2002;160:1335–1344.
references: Gabriel A, Porrino ML, Stephenson LL, Zamboni WA. Effect of L-arginine on leukocyte adhesion in ischemia-reperfusion injury. Plast Reconstr Surg. 2004;113:1698–1702.
references: Booi DI, Debats IB, Boeckx WD, van der Hulst RR. A study of perfusion of the distal free-TRAM flap using laser Doppler flowmetry. J Plast Reconstr Aesthet Surg. 2008;61:282–288.
references: Cheng MH, Robles JA, Gozel Ulusal B, Wei FC. Reliability of zone IV in the deep inferior epigastric perforator flap: A single center's experience with 74 cases. Breast 2006;16:158–166.
references: van Eijk HM, Rooyakkers DR, Deutz NE. Rapid routine determination of amino acids in plasma by high-performance liquid chromatography with a 2-3 microns Spherisorb ODS II column. J Chromatogr. 1993;620:143–148.
references: Tuominen HP, Asko-Seljavaara S, Svartling NE. Cutaneous blood flow in the free TRAM flap. Br J Plast Surg. 1993;46:665–669.
references: Booi DI, Debats IB, Boeckx WD, van der Hulst RR. Risk factors and blood flow in the free transverse rectus abdominis (TRAM) flap: Smoking and high flap weight impair the free TRAM flap microcirculation. Ann Plast Surg. 2007;59:364–371.
references: Peeters WJ, Nanhekhan L, Van Ongeval C, Fabré G, Vandevoort M. Fat necrosis in deep inferior epigastric perforator flaps: An ultrasound-based review of 202 cases. Plast Reconstr Surg. 2009;124:1754–1758.
references: Bozikov K, Arnez T, Hertl K, Arnez ZM. Fat necrosis in free DIEAP flaps: Incidence, risk, and predictor factors. Ann Plast Surg. 2009;63:138–142.
references: Enajat M, Rozen WM, Whitaker IS, Smit JM, Acosta R. A single center comparison of one versus two venous anastomoses in 564 consecutive DIEP flaps: Investigating the effect on venous congestion and flap survival. Microsurgery 2010;30:185–191.
references: Rozen WM, Pan WR, Le Roux CM, Taylor GI, Ashton MW. The venous anatomy of the anterior abdominal wall: An anatomical and clinical study. Plast Reconstr Surg. 2009;124:848–853.
references: Blondeel PN, Arnstein M, Verstraete K, et al. Venous congestion and blood flow in free transverse rectus abdominis myocutaneous and deep inferior epigastric perforator flaps. Plast Reconstr Surg. 2000;106:1295–1299.
references: Baumann DP, Lin HY, Chevray PM. Perforator number predicts fat necrosis in a prospective analysis of breast reconstruction with free TRAM, DIEP, and SIEA flaps. Plast Reconstr Surg. 2010;125:1335–1341.
references: Dirksen MT, Laarman GJ, Simoons ML, Duncker DJ. Reperfusion injury in humans: A review of clinical trials on reperfusion injury inhibitory strategies. Cardiovasc Res. 2007;74:343–355.
references: Khalil AA, Aziz FA, Hall JC. Reperfusion injury. Plast Reconstr Surg. 2006;117:1024–1033.
references: Tatlidede SH, Murphy AD, McCormack MC, et al. Improved survival of murine island skin flaps by prevention of reperfusion injury. Plast Reconstr Surg. 2009;123:1431–1439.
references: Khanna A, Cowled PA, Fitridge RA. Nitric oxide and skeletal muscle reperfusion injury: Current controversies (research review). J Surg Res. 2005;128:98–107.
references: Khiabani KT, Kerrigan CL. The effects of the nitric oxide donor SIN-1 on ischemia-reperfused cutaneous and myocutaneous flaps. Plast Reconstr Surg. 2002;110:169–176.
references: Küntscher MV, Juran S, Menke H, Gebhard MM, Erdmann D, Germann G. The role of pre-ischaemic application of the nitric oxide donor spermine/nitric oxide complex in enhancing flap survival in a rat model. Br J Plast Surg. 2002;55:430–433.
references: Khiabani KT, Kerrigan CL. Presence and activity of nitric oxide synthase isoforms in ischemia-reperfusion-injured flaps. Plast Reconstr Surg. 2002;109:1638–1645.
references: Kuo YR, Wang FS, Jeng SF, Lutz BS, Huang HC, Yang KD. Nitrosoglutathione promotes flap survival via suppression of reperfusion injury-induced superoxide and inducible nitric oxide synthase induction. J Trauma 2004;57:1025–1031.
references: Pernow J, Bohm F, Beltran E, Gonon A. L-arginine protects from ischemia-reperfusion-induced endothelial dysfunction in humans in vivo. J Appl Physiol. 2003;95:2218–2222.
references: Nanobashvili J, Neumayer C, Fuegl A, et al. Combined L-arginine and antioxidative vitamin treatment mollifies ischemia-reperfusion injury of skeletal muscle. J Vasc Surg. 2004;39:868–877.
references: Ambros JT, Herrero-Fresneda I, Borau OG, Boira JM. Ischemic preconditioning in solid organ transplantation: From experimental to clinics. Transpl Int. 2007;20:219–229.